NewsRx

Search our medical news database

Legal Issues

Omnicare to contribute to NCS stockholder escrow fund

Published in Managed Care Weekly Digest, January 27th, 2003

Omnicare, Inc., (OCR), a provider of pharmaceutical care for the elderly, announced that it has agreed, subject to court approval, to contribute $4,500,000 to the $13,500,000 stockholder escrow fund which the Delaware Chancery Court has ordered be entirely funded with amounts withheld from the aggregate amount payable to stockholders of NCS HealthCare, Inc. (NCSS).

On January 2, 2003, Omnicare was enjoined by the Delaware Chancery Court from paying $13,500,000 of the aggregate amount payable to stockholders of NCS in Omnicare's tender offer and merger and was ordered to deposit such amount in an interest-bearing escrow account pending a determination by the Chancery...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook